GSK3145095
目录号: A19427
RIP1 kinase 抑制剂
GSK3145095 是一种 RIP1激酶抑制剂,其 IC50 为 6.3 nM。
Discription | GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM . | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A19427 |
---|---|
分子式 | C20H17F2N5O2 |
分子量 | 397.38 |
CAS号 | 1622849-43-7 |
SMILES | FC1=CC(F)=CC2=C1NC([C@@H](NC(C3=NNC(CC4=CC=CC=C4)=N3)=O)CC2)=O |
其他名称 | GSK-3145095; GSK 3145095 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 74 mg/mL (186.22 mM) | |
Water | Insoluble | ||
Ethanol | 6 mg/mL (15.09 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.16 mL | 125.82 mL | 251.65 mL |
0.5 mM | 5.03 mL | 25.16 mL | 50.33 mL |
1 mM | 2.52 mL | 12.58 mL | 25.16 mL |
5 mM | 0.5 mL | 2.52 mL | 5.03 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2